Sarah Cannon

How We’re Advancing Blood Cancer Care Through Cellular Therapy

Issue link: http://sarahcannon.uberflip.com/i/1190396

Contents of this Issue

Navigation

Page 0 of 1

Learn more about us at sarahcannon.com/bloodcancernetwork How We're Advancing Blood Cancer Care Through Cellular Therapy Hematopoietic Cell Transplantation Patients Enrolled to Blood Cancer Trials Per Year Across the Network 400+ 12,000+ Hematopoietic Cell Transplants (HCTs) Performed to Date Comprehensive Network Approach for Patient Care Blood Cancer Publications to Date 350+ HCTs Performed Each Year 1,200+ Together, we provide state-of-the-art blood cancer care close to home for tens of thousands of patients, a number unmatched by any single cancer center. Standardized HCT Pathways Comprehensive Patient Management Software 13 1 1 Set of Patient Eligibility Criteria Quality Plan 1122/19SCB29-4/R4 Providing Hematopoietic Cell Transplants Largest Network 9 FACT/JACIE Accredited Hematopoietic Cell Transplant Programs Across the U.S. and UK AUSTIN DALLAS DENVER NASHVILLE NEW ORLEANS LONDON, UK MANCHESTER, UK SAN ANTONIO

Articles in this issue

Links on this page

view archives of Sarah Cannon - How We’re Advancing Blood Cancer Care Through Cellular Therapy